OptiBiotix Health PLC’s (LON:OPTI) Corporate Rating Reiterated at FinnCap
OptiBiotix Health PLC (LON:OPTI)‘s stock had its “corporate” rating reissued by FinnCap in a report released on Tuesday, July 11th.
OptiBiotix Health PLC (LON:OPTI) traded up 0.19% during midday trading on Tuesday, reaching GBX 64.62. The company’s stock had a trading volume of 3,400 shares. The firm’s market cap is GBX 50.50 million. OptiBiotix Health PLC has a one year low of GBX 59.00 and a one year high of GBX 90.00. The firm has a 50 day moving average price of GBX 66.69 and a 200 day moving average price of GBX 72.08.
ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/07/optibiotix-health-plc-lonopti-receives-corporate-rating-from-finncap-updated-updated-updated.html.
About OptiBiotix Health PLC
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.
Receive News & Stock Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related stocks with our FREE daily email newsletter.